Mononuclear Cells, Platelets and Zoledronic Acid for Preventing Collapse of the Femoral Head in Osteonecrosis
Status:
Unknown status
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
This study was mainly aimed to evaluate the efficacy of local administration of enriched bone
marrow mononuclear cells, platelets and zoledronic acid for the clinical prevention of
collapse of the early-stage osteonecrotic femoral head.